Showing results (361-370 of 623) with videos related to
Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trialJ S Abrams, D A Vena, J Baltz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve AccrualHolly A Massett, Grace Mishkin, Larry Rubinstein, et al.Blood|July 26, 2018
Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in miceMaegan Capitano, Liang Zhao, Scott Cooper, et al.Academic Radiology|July 31, 2007
Interactive computer-aided diagnosis of breast masses: computerized selection of visually similar image sets from a reference libraryBin Zheng, Claudia Mello-Thoms, Xiao-Hui Wang, et al.European Urology Oncology|December 4, 2020
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the LiteratureRaisa S Abrams-Pompe, Stefano Fanti, Ivo G Schoots, et al.American Journal of Respiratory and Critical Care Medicine|April 1, 1996
Cytokine production at the site of disease in chronic eosinophilic pneumonitisH Kita, S Sur, L W Hunt, et al.Frontiers in Surgery|February 28, 2022
Urethral Stricture Formation Following Cuff Erosion of AMS Artificial Urinary Sphincter Devices: Implication for a Less Invasive Explantation ApproachKatharina Kuhlencord, Roland Dahlem, Malte W Vetterlein, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993
Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trialJ S Abrams, J L Eiseman, T J Melink, et al.Journal of the National Cancer Institute|July 18, 1990
High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinomaJ S Abrams, A A Rayner, P H Wiernik, et al.Blood|October 13, 2011
Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interactionYuhuan Wang, Ronghua Meng, Vincent Hayes, et al.Pageof 63